Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]

Detalles Bibliográficos
Autores principales: Mirmohammadi, Seyedeh Mozhdeh, Kianmehr, Anvarsadat, Sabbaghian, Amir, Mohebbi, Alireza, Shahbazmohammadi, Hamid, Sheikharabi, Mehdi, Bazzi, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458589/
https://www.ncbi.nlm.nih.gov/pubmed/36089457
http://dx.doi.org/10.1016/j.meegid.2022.105361
_version_ 1784786325553020928
author Mirmohammadi, Seyedeh Mozhdeh
Kianmehr, Anvarsadat
Sabbaghian, Amir
Mohebbi, Alireza
Shahbazmohammadi, Hamid
Sheikharabi, Mehdi
Bazzi, Zahra
author_facet Mirmohammadi, Seyedeh Mozhdeh
Kianmehr, Anvarsadat
Sabbaghian, Amir
Mohebbi, Alireza
Shahbazmohammadi, Hamid
Sheikharabi, Mehdi
Bazzi, Zahra
author_sort Mirmohammadi, Seyedeh Mozhdeh
collection PubMed
description
format Online
Article
Text
id pubmed-9458589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94585892022-09-09 Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318] Mirmohammadi, Seyedeh Mozhdeh Kianmehr, Anvarsadat Sabbaghian, Amir Mohebbi, Alireza Shahbazmohammadi, Hamid Sheikharabi, Mehdi Bazzi, Zahra Infect Genet Evol Article Published by Elsevier B.V. 2022-10 2022-09-09 /pmc/articles/PMC9458589/ /pubmed/36089457 http://dx.doi.org/10.1016/j.meegid.2022.105361 Text en © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mirmohammadi, Seyedeh Mozhdeh
Kianmehr, Anvarsadat
Sabbaghian, Amir
Mohebbi, Alireza
Shahbazmohammadi, Hamid
Sheikharabi, Mehdi
Bazzi, Zahra
Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title_full Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title_fullStr Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title_full_unstemmed Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title_short Corrigendum to “In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19” [Infection, Genetics and Evolution 103 (2022) 105318]
title_sort corrigendum to “in silico drug repurposing against sars-cov-2 using an integrative transcriptomic profiling approach: hydrocortisone and benzhydrocodone as potential drug candidates against covid-19” [infection, genetics and evolution 103 (2022) 105318]
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458589/
https://www.ncbi.nlm.nih.gov/pubmed/36089457
http://dx.doi.org/10.1016/j.meegid.2022.105361
work_keys_str_mv AT mirmohammadiseyedehmozhdeh corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT kianmehranvarsadat corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT sabbaghianamir corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT mohebbialireza corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT shahbazmohammadihamid corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT sheikharabimehdi corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318
AT bazzizahra corrigendumtoinsilicodrugrepurposingagainstsarscov2usinganintegrativetranscriptomicprofilingapproachhydrocortisoneandbenzhydrocodoneaspotentialdrugcandidatesagainstcovid19infectiongeneticsandevolution1032022105318

Ejemplares similares